☘️ St. Patrick's Day Sale — code ANNUAL50 for 50% off your first yearEnds in --d --h --m --sSign up now →
4532.8%
Est. daily mentions on Stocktwits.
Loading...

Sign up to access historical data

Sign up

Month over Month

Est. daily mentions on Stocktwits.

Feb 2026 47
Jan 2026 61
Dec 2025 99
Nov 2025 111
Oct 2025 45

How often is Arrowhead Pharmaceuticals mentioned on StockTwits?

Arrowhead Pharmaceuticals was mentioned an estimated 45 times in discussions on StockTwits yesterday.

Analyzing Stocktwits Mentions, how is Arrowhead Pharmaceuticals performing compared to its industry peers?

Arrowhead Pharmaceuticals underperforms its industry peers when it comes to Stocktwits Mentions, ranking in the 1st percentile.

What does a high frequency of StockTwits mentions indicate for Arrowhead Pharmaceuticals' market sentiment?

A high frequency of mentions on StockTwits for Arrowhead Pharmaceuticals could indicate strong market interest or sentiment towards the company. It often reflects the trading community's engagement with Arrowhead Pharmaceuticals' stock, potentially signaling bullish or bearish trends based on the context of the discussions.

How often does AltIndex update information on Arrowhead Pharmaceuticals' mentions on StockTwits?

AltIndex updates the data on Arrowhead Pharmaceuticals' mentions on StockTwits daily. This frequent update schedule ensures that investors have access to the most current insights into market sentiment and discussion dynamics related to Arrowhead Pharmaceuticals' on the platform.

Sign up and get more insights on Arrowhead Pharmaceuticals.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.